p140Cap enhances breast cancer chemosensitivity by limiting an ABCC1-enriched stem-like compartment via β-Catenin inhibition
Scavuzzo, A.; Poncina, M.; Lamolinara, A.; Sarcinella, A.; Jahanbin, M.; Filippone, M. G.; Bottoni, L.; Tucci, F. A.; Vinik, Y.; Lev, S.; Iezzi, M.; Ala, U.; Taverna, D.; Orso, F.; Belletti, B.; Turco, E.; Pece, S.; Tosoni, D.; Defilippi, P.; Salemme, V.
Show abstract
Chemotherapy response in breast cancer is highly heterogeneous and influenced by tumor-intrinsic drivers of drug sensitivity, including cancer stem cell abundance. We previously reported that the scaffold protein p140Cap limits breast cancer stem cell traits and delays tumor progression. Here, we investigated the role of p140Cap in shaping sensitivity to chemotherapy in HER2-positive and triple-negative breast cancer. In preclinical and patient-derived models, p140Cap enhances chemotherapy response by increasing intracellular doxorubicin retention, DNA damage and subsequent apoptosis. Mechanistically, p140Cap constrained a doxorubicin-negative side population enriched for stem-like properties and elevated ABCC1 expression via inhibition of {beta}-Catenin signaling. Constitutively active {beta}-Catenin expression reversed this phenotype, whereas pharmacological inhibition of the Wnt/{beta}-Catenin pathway with IWR-1 or LGK-974 sensitized p140Cap-deficient tumors to chemotherapy. Clinically, analyses of breast cancer cohorts and patient-derived xenograft models identify p140Cap as predictive biomarker of chemotherapy response, proposing p140Cap-guided patient stratification, dose optimization and rational combination therapies.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Translational control of breast cancer plasticity 96%
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 95%
- Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction 95%
Similar papers in this journal
- HIF-1 regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancer 94%
- Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation 94%
- The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer 94%
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 94%
- Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations 93%
- Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs 93%
Similar papers in this journal
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring 93%
- Decoy Antibodies Block Extracellular HSP70, Prevent Self Signaling and Inhibit Melanoma Cell Survival 93%
- GLIS3 Marks a Neural-like Progenitor Cell State that Drives Metastasis in Pancreatic Ductal Adenocarcinoma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.